Clinical Trial Update: An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric [Phase 2, Phase 3]

View source ↗

Summary

Exploratory clinical study evaluating Apatinib as a second-line treatment for esophageal cancer or esophageal/gastric cardia conditions; phases 2 and 3, status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Gastric Cardia Metaplasia

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Esophagus Cancer, Stage III, Esophageal Gastric Cardia Type Metaplasia | Phase 2, Phase 3 | Status: UNKNOWN